Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical statistics
86 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.15
- 4.85
- P/OCF Ratio
- 67.76
- 22.12
Enterprise valuationIndustry
- EV / Sales
- 0.36
- 2.70
Share statisticsIndustry
- Shares Change (YoY)
- 2.67%
- 3.22%
- Shares Change (QoQ)
- 0.14%
- 0.16%
- Shares Held by Institutions
- 106.0%
- 60.2%
Short sellingIndustry
- Short Interest
- 375,281
- –
- Short Interest Change
- 24.9%
- -2.57%
- Short % of Shares Outstanding
- 0.27%
- 3.98%
- Days to Cover
- 3.86
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $0.84
- –
- 52-Week Low
- $0.27
- –
- 20-Day Moving Average
- $0.29
- –
- 50-Day Moving Average
- $0.32
- –
- 200-Day Moving Average
- $0.45
- –
- Average True Range (14)
- $0.02
- –
- Price Change (1 Week)
- -8.23%
- 2.01%
- Price Change (1 Month)
- -13.6%
- -0.57%
- Price Change (3 Months)
- -9.74%
- -7.91%
- Price Change (6 Months)
- -41.4%
- -0.90%
- Price Change (YTD)
- -64.9%
- -0.82%
- Price Change (1 Year)
- -63.6%
- -1.18%
- Price Change (3 Years)
- -76.5%
- 6.56%
- Price Change (5 Years)
- -75.0%
- -49.8%
- Price Change (10 Years)
- -96.1%
- 57.3%
- Average Volume (10 Days)
- 205,514
- –
- Average Volume (20 Days)
- 153,956
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.12
- 0.82
- Relative Strength Index (14)
- 38.8
- 47.7
- Volatility (1 Year)
- 63.1%
- 64.2%
- Beta (5 Years)
- 0.60
- 1.05
MarginsIndustry
- Pretax Margin
- -8.44%
- -2.55%
- EBITDA Margin
- -5.91%
- -2.82%
- FCF Margin
- -0.64%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- -25.2%
- -17.1%
- Return on Assets (ROA)
- -12.2%
- -12.2%
- Return on Invested Capital (ROIC)
- -15.8%
- -3.22%
- Return on Capital Employed (ROCE)
- -21.1%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.16
- 2.45
- Quick Ratio
- 0.98
- 1.53
- Debt / Equity
- 0.28
- 0.42
- Interest Coverage
- -3.80
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- -14.3%
- 9.24%
- Revenue Growth (3Y CAGR)
- 32.2%
- 7.08%
- Revenue Growth (5Y CAGR)
- 20.2%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 1.20
- 0.59
- Inventory Turnover
- 1.21
- 2.20
- Revenue Per Employee
- $725.34K
- $330.60K
- Profits Per Employee
- -$73.76K
- -$41.39K
- Employee Count
- 151
- 186
- WACC
- 8.75%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- -$9.24M
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- -$1.14M
- $3.73M
- Net Cash Per Share
- -$0.01
- $0.24
- Equity (Book Value)
- $40.02M
- $63.44M
- Book Value Per Share
- $0.29
- $3.26
- Tangible Book Value
- $33.69M
- $11.04M
- Working Capital
- $34.81M
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.27M
- -$3.69M
- FCF Per Share
- -$0.00
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- -28.8%
- -4.70%
- FCF Yield
- -1.80%
- 0.24%
Taxes and interestIndustry
- Interest Expense
- $2.76M
- $5.33M
- Income Tax
- $1.90M
- $1.63M
Scores and fair valueIndustry
- Altman Z-Score
- -2.64
- 2.44
- Piotroski F-Score
- 8
- 5
- Beneish M-Score
- -3.11
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | XTNT | S&P 500 | Difference | XTNT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -16.3% | -2.7% | −13.6 pts | ||
| 3 months | -11.3% | -1.7% | −9.6 pts | ||
| Year to date | -64.9% | +11.9% | −76.8 pts | ||
| 1 year | -61.9% | +12.0% | −73.9 pts | ||
| 3 years | -76.5% | +78.2% | −154.6 pts | -38.3% | +21.2% |
| 5 years | -75.0% | +73.2% | −148.2 pts | -24.2% | +11.6% |
| 10 years | -96.1% | +309.6% | −405.8 pts | -27.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M XTNT shares were sold short on Oct 30, 2026, up 24.9% from the previous report. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 32.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 375,281 | +24.9% | 97,274 | 3.9 |
| Oct 15, 2026 | 300,482 | +109.3% | 92,193 | 3.3 |
| Sep 30, 2026 | 143,564 | -46.6% | 239,833 | 1.0 |
| Sep 15, 2026 | 268,742 | -85.3% | 1,305,660 | 1.0 |
| Aug 31, 2026 | 1,828,008 | +1667.8% | 8,029,553 | 1.0 |
| Aug 14, 2026 | 103,406 | +16.2% | 232,810 | 1.0 |
| Jul 31, 2026 | 88,962 | +27.0% | 51,996 | 1.7 |
| Jul 15, 2026 | 70,049 | +2058.7% | 138,637 | 1.0 |
| Jun 30, 2026 | 3,245 | +107.0% | 59,123 | 1.0 |
| Jun 15, 2026 | 1,568 | -59.4% | 106,636 | 1.0 |
| May 29, 2026 | 3,862 | -80.1% | 183,166 | 1.0 |
| May 15, 2026 | 19,453 | -72.4% | 159,209 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?